Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EXPD | CNP |
|---|---|---|
| Price | $186.75 | $36.85 |
| Change today | ▲ 1.14% | ▲ 0.12% |
| Market cap | $24.28B | $24.27B |
| Return, 3 months | +12.0% | -15.2% |
| Return, year to date | +26.0% | -2.3% |
| Return, 1 year | +55.3% | -1.3% |
| P/E (TTM) | 27.2 | 21.9 |
| P/B | 11.5 | 2.1 |
| P/E percentile vs own 5y | 95th | 54th |
| Dividend yield | 0.85% | 2.44% |
| Revenue growth (YoY, latest qtr) | +32.1% | +10.7% |
| Net profit growth (YoY) | +45.3% | +23.2% |
| Gross margin | 12.9% | 46.7% |
| Operating margin | 9.8% | 23.2% |
| Net margin | 7.6% | 11.6% |
| Return on equity | 42.6% | 9.8% |
| Analyst target vs. price | -2.5% | +24.6% |
| Analyst buy share | 30% | 60% |
| RSI (14) | 45 | 30 |
| 30-day volatility | 18.6% | 17.4% |
| Max drawdown, 1 year | -15.9% | -18.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
